| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaccinex, Inc. (VCNX) has 0 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. VCNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | Van Strydonck, Gerald E. | Director | Buy | 20,000 | $1.32 | $26,360.00 | +1,000% | |
| Jan 27, 2022 | Friedberg Albert | Director, 10% Owner | Buy | 3,603,602 | $1.11 | $3,999,998.22 | +31.4% | |
| Jan 27, 2022 | Zauderer Maurice | President And CEO | Buy | 1,801,801 | $1.11 | $1,999,999.11 | +164.1% | |
| Jan 27, 2022 | Frieberg Jacob B. | Director | Buy | 90,090 | $1.11 | $99,999.90 | +2,038% | |
| Jul 10, 2020 | Friedberg Albert | Director, 10% Owner | Buy | 1,126,760 | $3.55 | $3,999,998.00 | +193.2% | |
| Mar 30, 2020 | Friedberg Albert | Director, 10% Owner | Buy | 9,000 | $4.11 | $37,020.00 | - | |
| Mar 26, 2020 | Friedberg Albert | Director, 10% Owner | Buy | 3,000 | $4.41 | $13,240.00 | - | |
| Mar 20, 2020 | Friedberg Albert | Director, 10% Owner | Buy | 6,000 | $4.20 | $25,220.00 | - | |
| Mar 17, 2020 | Friedberg Albert | Director, 10% Owner | Buy | 7,040 | $4.13 | $29,090.00 | - | |
| Mar 10, 2020 | Friedberg Albert | Director, 10% Owner | Buy | 4,231 | $4.20 | $17,774.82 | - |